Solid Tumor Malignancies: Clinical Trials

3 trials for Solid Tumor Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3

Follow Solid Tumor Malignancies: new trials by email Literature Review of Solid Tumor Malignancies trials Research Report on Solid Tumor Malignancies

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
Clostridium novyi-NT spores - Solid Tumor Malignancies
Phase 1TerminatedBioMed Valley Discoveries, Inc52011-04-012016-01-20
A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies
ASA404, DMXAA, DXAA - Solid Tumor Malignancies
Phase 1TerminatedNovartis Pharmaceuticals542010-02-012011-09-02
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
ATRA-IV, Depakote - Solid Tumor Malignancies
Phase 1TerminatedWeill Medical College of Cornell University2003-07-012006-09-14

Narrower conditions

Hypoxia (1)  ·  Necrosis (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)

Broader conditions

Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

Bacterial Load (1)  ·  Valproic Acid (1)  ·  vadimezan (1)

Sponsors

BioMed Valley Discoveries, Inc (1)  ·  Novartis Pharmaceuticals (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (3)

Top investigators

David Nanus, M.D. (1)

Results publications

PMID 31811682